Viewing Study NCT06100783



Ignite Creation Date: 2024-05-06 @ 7:42 PM
Last Modification Date: 2024-10-26 @ 3:12 PM
Study NCT ID: NCT06100783
Status: COMPLETED
Last Update Posted: 2023-10-25
First Post: 2023-10-15

Brief Title: Depot-medroxy Progesterone Acetate Injectable Contraceptives in Lactating Women 1st Week Versus 6 Week Postpartum Initiation
Sponsor: Assiut University
Organization: Assiut University

Study Overview

Official Title: Depot-medroxy Progesterone Acetate Injectable Contraceptives in Lactating Women 1st Week Versus 6 Week Postpartum Initiation
Status: COMPLETED
Status Verified Date: 2023-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aims to identify the effect of using Depot-medroxy progesterone acetate injectable contraceptives on lactating women mother and infant in 1st week versus 6th week postpartum initiation

This study is open labeled -randomized clinical trial was used It was conducted at womans health hospital Assuit University This study applied on 120 lactating women who divided into two equal group I who used DMPA injectable in the 1st week postpartum and group II who used DMPA injectable in the 6th week postpartum Each group included 60 lactating women Follow up was carried out after 3 months from the first dose to determine the changes in the studied womens menstrual period weight breast feedingsetc
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None